Retractable Technologies Q1 sales fall, operating loss widens

Retractable Technologies

15/05/2026 21:27

Overview

U.S. safety medical device maker's Q1 sales fell 13% yr/yr, operating loss widened

Sales decline driven by lower average selling prices and higher international sales mix

Company cut workforce by 16% in April to reduce annual wage and benefit costs

Outlook

Company expects recent workforce reduction to save about $2.2 mln in annual wage costs

Company says tariffs may continue to materially impact costs in future periods

Company notes uncertainty regarding timing of future international orders

Result Drivers

SALES MIX SHIFT - Higher proportion of international sales, which carry lower average selling prices, contributed to lower overall revenues

PRODUCT MIX AND PRICING - Decrease in average selling price due to product mix changes and higher transaction costs from distributor agreements

OPERATING EXPENSES - Operating expenses rose 14%, mainly due to non-recurring consulting expenses and charitable product donations

Company press release: ID:nBw4wmmNLa

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
$7.2 mln
Q1 Operating Income
-$6.2 mln


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)